Singapore markets closed
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,018.39 -17.30 (-0.34%) Dow
37,903.29 +87.37 (+0.23%) Nasdaq
15,605.48 -52.34 (-0.33%) Bitcoin USD
58,792.58 +684.41 (+1.18%) CMC Crypto 200
1,270.12 -0.62 (-0.05%)
GSK plc (GSK)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 41.44 |
| Open | 42.70 |
| Bid | 42.53 x 1200 |
| Ask | 42.51 x 1100 |
| Day's range | 42.28 - 42.84 |
| 52-week range | 33.33 - 43.84 |
| Volume | |
| Avg. volume | 3,445,390 |
| Market cap | 86.8B |
| Beta (5Y monthly) | 0.27 |
| PE ratio (TTM) | 15.59 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.47 (3.45%) |
| Ex-dividend date | 16 May 2024 |
| 1y target est | N/A |
- Simply Wall St.
GSK First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
GSK ( LON:GSK ) First Quarter 2024 Results Key Financial Results Revenue: UK£7.36b (up 5.9% from 1Q 2023). Net income...
- Benzinga
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Wednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling Pounds), up 10% Y/Y and 13% excluding COVID. Vaccines’ sales increased 16% at constant currency to 2.28 billion Pounds, reflecting U.S. demand for Arexvy and strong market growth for Shingrix in International and European markets. Shingrix sales reached 945 million Pounds, up 18% at constant currency, with Arexvy sales of 182 million Pounds. Specialty Medicine sales increased 17% to 2.5 billion poun
- PA Media: Money
GSK raises profit guidance as vaccine demand grows
Emma Walmsley, chief executive officer of the pharmaceutical firm hailed a ‘strong start to 2024’.
© 2024 Yahoo. All rights reserved.